PAR News: Paradigm Biopharmaceuticals Retains Rubenstein Public Relations as Agency of Record - 20th Apr 2022, 3:10am

annb0t

Top 20
Global Biopharmaceutical Company Hires Leading PR Firm as it Expands Their U.S. Operations

NEW YORK, April 19, 2022 /PRNewswire/ -- Paradigm Biopharmaceuticals ("Paradigm"), a global biopharmaceutical company specializing in repurposing existing drugs for unmet medical needs, announced their retention of Rubenstein Public Relations (RPR) as its agency of record. Paradigm Biopharma (PRNewsfoto/Paradigm Biopharmaceuticals)

Paradigm recently announced the expansion of their U.S. operations to sup...

>>> Read more: Paradigm Biopharmaceuticals Retains Rubenstein Public Relations as Agency of Record
 
  • Like
Reactions: 1 users
Top Bottom